Index
1 Inactivated Polio Vaccine Market Overview
1.1 Inactivated Polio Vaccine Product Overview
1.2 Inactivated Polio Vaccine Market Segment by Type
1.2.1 Government
1.2.2 Private Sector
1.3 Global Inactivated Polio Vaccine Market Size by Type
1.3.1 Global Inactivated Polio Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Inactivated Polio Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Inactivated Polio Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
2 Global Inactivated Polio Vaccine Market Competition by Company
2.1 Global Top Players by Inactivated Polio Vaccine Sales (2018-2023)
2.2 Global Top Players by Inactivated Polio Vaccine Revenue (2018-2023)
2.3 Global Top Players by Inactivated Polio Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Inactivated Polio Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inactivated Polio Vaccine Market Competitive Situation and Trends
2.5.1 Inactivated Polio Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Inactivated Polio Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Inactivated Polio Vaccine Market
2.8 Key Manufacturers Inactivated Polio Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inactivated Polio Vaccine Status and Outlook by Region
3.1 Global Inactivated Polio Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inactivated Polio Vaccine Historic Market Size by Region
3.2.1 Global Inactivated Polio Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Inactivated Polio Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Inactivated Polio Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Inactivated Polio Vaccine Forecasted Market Size by Region
3.3.1 Global Inactivated Polio Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Inactivated Polio Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Inactivated Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inactivated Polio Vaccine by Application
4.1 Inactivated Polio Vaccine Market Segment by Application
4.1.1 Pediatrics
4.1.2 Adults
4.2 Global Inactivated Polio Vaccine Market Size by Application
4.2.1 Global Inactivated Polio Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Inactivated Polio Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Inactivated Polio Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
5 North America Inactivated Polio Vaccine by Country
5.1 North America Inactivated Polio Vaccine Historic Market Size by Country
5.1.1 North America Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inactivated Polio Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Inactivated Polio Vaccine Sales in Value by Country (2018-2023)
5.2 North America Inactivated Polio Vaccine Forecasted Market Size by Country
5.2.1 North America Inactivated Polio Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Inactivated Polio Vaccine Sales in Value by Country (2024-2029)
6 Europe Inactivated Polio Vaccine by Country
6.1 Europe Inactivated Polio Vaccine Historic Market Size by Country
6.1.1 Europe Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inactivated Polio Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Inactivated Polio Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Inactivated Polio Vaccine Forecasted Market Size by Country
6.2.1 Europe Inactivated Polio Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Inactivated Polio Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Inactivated Polio Vaccine by Region
7.1 Asia-Pacific Inactivated Polio Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inactivated Polio Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Inactivated Polio Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Inactivated Polio Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Inactivated Polio Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inactivated Polio Vaccine Sales in Value by Region (2024-2029)
8 Latin America Inactivated Polio Vaccine by Country
8.1 Latin America Inactivated Polio Vaccine Historic Market Size by Country
8.1.1 Latin America Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inactivated Polio Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Inactivated Polio Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Inactivated Polio Vaccine Forecasted Market Size by Country
8.2.1 Latin America Inactivated Polio Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inactivated Polio Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Inactivated Polio Vaccine by Country
9.1 Middle East and Africa Inactivated Polio Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inactivated Polio Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Inactivated Polio Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Inactivated Polio Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Inactivated Polio Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inactivated Polio Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Inactivated Polio Vaccine Products Offered
10.1.5 Sanofi Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Inactivated Polio Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Bibcol
10.3.1 Bibcol Company Information
10.3.2 Bibcol Introduction and Business Overview
10.3.3 Bibcol Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bibcol Inactivated Polio Vaccine Products Offered
10.3.5 Bibcol Recent Development
10.4 Serum Institute
10.4.1 Serum Institute Company Information
10.4.2 Serum Institute Introduction and Business Overview
10.4.3 Serum Institute Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Serum Institute Inactivated Polio Vaccine Products Offered
10.4.5 Serum Institute Recent Development
10.5 Tiantan Biological
10.5.1 Tiantan Biological Company Information
10.5.2 Tiantan Biological Introduction and Business Overview
10.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Tiantan Biological Inactivated Polio Vaccine Products Offered
10.5.5 Tiantan Biological Recent Development
10.6 Panacea Biotec
10.6.1 Panacea Biotec Company Information
10.6.2 Panacea Biotec Introduction and Business Overview
10.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Panacea Biotec Inactivated Polio Vaccine Products Offered
10.6.5 Panacea Biotec Recent Development
10.7 Bio-Med
10.7.1 Bio-Med Company Information
10.7.2 Bio-Med Introduction and Business Overview
10.7.3 Bio-Med Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bio-Med Inactivated Polio Vaccine Products Offered
10.7.5 Bio-Med Recent Development
10.8 Halfkin Bio-Pharmaceuticals
10.8.1 Halfkin Bio-Pharmaceuticals Company Information
10.8.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Products Offered
10.8.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inactivated Polio Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inactivated Polio Vaccine Industrial Chain Analysis
11.4 Inactivated Polio Vaccine Market Dynamics
11.4.1 Inactivated Polio Vaccine Industry Trends
11.4.2 Inactivated Polio Vaccine Market Drivers
11.4.3 Inactivated Polio Vaccine Market Challenges
11.4.4 Inactivated Polio Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inactivated Polio Vaccine Distributors
12.3 Inactivated Polio Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer